861 resultados para false discovery


Relevância:

20.00% 20.00%

Publicador:

Relevância:

20.00% 20.00%

Publicador:

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Wednesday 23rd April 2014 Speaker(s): Willi Hasselbring Organiser: Leslie Carr Time: 23/04/2014 14:00-15:00 Location: B32/3077 File size: 802Mb Abstract The internal behavior of large-scale software systems cannot be determined on the basis of static (e.g., source code) analysis alone. Kieker provides complementary dynamic analysis capabilities, i.e., monitoring/profiling and analyzing a software system's runtime behavior. Application Performance Monitoring is concerned with continuously observing a software system's performance-specific runtime behavior, including analyses like assessing service level compliance or detecting and diagnosing performance problems. Architecture Discovery is concerned with extracting architectural information from an existing software system, including both structural and behavioral aspects like identifying architectural entities (e.g., components and classes) and their interactions (e.g., local or remote procedure calls). In addition to the Architecture Discovery of Java systems, Kieker supports Architecture Discovery for other platforms, including legacy systems, for instance, inplemented in C#, C++, Visual Basic 6, COBOL or Perl. Thanks to Kieker's extensible architecture it is easy to implement and use custom extensions and plugins. Kieker was designed for continuous monitoring in production systems inducing only a very low overhead, which has been evaluated in extensive benchmark experiments. Please, refer to http://kieker-monitoring.net/ for more information.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

El artículo busca demostrar las inconsistencias del pensamiento estratégico de Porter desde el punto de vista metodológico y epistemológico. De igual manera, muestra que las propuestas praxológicas de Porter son imposibles de operacionalizar y normativizar. Además, la teoría carece de factores fundamentales que permitan a las organizaciones perdurar y ser exitosas en el tiempo teniendo ventaja defendible y difícilmente imitable.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Resumen tomado de la publicación

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Resumen tomado de la publicaci??n

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Resumen tomado de la publicaci??n

Relevância:

20.00% 20.00%

Publicador:

Resumo:

The purpose of this study was to evaluate the effectiveness of a hearing screening program, particularly focusing on hit and false positive rates in the NICU and WBN at a top-rated birthing hospital in Saint Louis, MO. Additionally, the study examined how these rates may be influenced by risk factors for hearing loss.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

n this new CEPS commentary, CEPS Director Daniel Gros takes a closer look at the US experience to point out that the federal budget provides much less insurance against state specific shocks than widely assumed, while the US Banking Union act as a very powerful shock absorber. Accordingly, he argues that the euro’s long-term stability depends far more on completing plans for a European banking union than on the introduction of a fiscal capacity for the eurozone.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Observation of adverse drug reactions during drug development can cause closure of the whole programme. However, if association between the genotype and the risk of an adverse event is discovered, then it might suffice to exclude patients of certain genotypes from future recruitment. Various sequential and non-sequential procedures are available to identify an association between the whole genome, or at least a portion of it, and the incidence of adverse events. In this paper we start with a suspected association between the genotype and the risk of an adverse event and suppose that the genetic subgroups with elevated risk can be identified. Our focus is determination of whether the patients identified as being at risk should be excluded from further studies of the drug. We propose using a utility function to? determine the appropriate action, taking into account the relative costs of suffering an adverse reaction and of failing to alleviate the patient's disease. Two illustrative examples are presented, one comparing patients who suffer from an adverse event with contemporary patients who do not, and the other making use of a reference control group. We also illustrate two classification methods, LASSO and CART, for identifying patients at risk, but we stress that any appropriate classification method could be used in conjunction with the proposed utility function. Our emphasis is on determining the action to take rather than on providing definitive evidence of an association. Copyright (C) 2008 John Wiley & Sons, Ltd.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Resistant strains of Plasmodium falciparum and the unavailability of useful antimalarial vaccines reinforce the need to develop new efficacious antimalarials. This study details a pharmacophore model that has been used to identify a potent, soluble, orally bioavailable antimalarial bisquinoline, metaquine (N,N'-bis(7-chloroquinolin-4-yl)benzene-1,3-diamine) (dihydrochloride), which is active against Plasmodium berghei in vivo (oral ID50 of 25 mu mol/kg) and multidrug-resistant Plasmodium falciparum K1 in vitro (0.17 mu M). Metaquine shows strong affinity for the putative antimalarial receptor, heme at pH 7.4 in aqueous DMSO. Both crystallographic analyses and quantum mechanical calculations (HF/6-31+G*) reveal important regions of protonation and bonding thought to persist at parasitic vacuolar pH concordant with our receptor model. Formation of drug-heme adduct in solution was confirmed using high-resolution positive ion electrospray mass spectrometry. Metaquine showed strong binding with the receptor in a 1: 1 ratio (log K = 5.7 +/- 0.1) that was predicted by molecular mechanics calculations. This study illustrates a rational multidisciplinary approach for the development of new 4-aminoquinoline antimalarials, with efficacy superior to chloroquine, based on the use of a pharmacophore model.